|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.4040 - 0.4040|
|52 Week Range||0.1590 - 0.7150|
|Beta (5Y Monthly)||1.30|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Toronto, Ontario--(Newsfile Corp. - October 19, 2020) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that the previously announced asset purchase agreement with CMAX Technologies Inc. ("CMAX"), a related party of the Company has closed (the "CMAX Transaction"). Pursuant to the CMAX Transaction, Canntab has acquired certain cannabis-processing ...
LÉVIS, QC, Oct. 6, 2020 /CNW Telbec/ - Canada Economic Development for Quebec Regions (CED) Élisabeth Brière, Parliamentary Secretary to the Minister of Economic Development and Official Languages (Economic Development Agency of Canada for the Regions of Quebec), will announce Government of Canada financial support for Développement PME (DPME) de Chaudière-Appalaches.
VANCOUVER, BC, Sept. 21, 2020 /CNW/ - Trading resumes in:Company: Canntab Therapeutics LimitedCSE Symbol: PILLAll Issues: YesResumption (ET): 10:00 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company.